Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesImiglucerase and its use for the treatment of Gaucher's disease
Expert Opinion in Pharmacotherapy, 07/24/08
Weinreb NJ - Imiglucerase is safe and well tolerated. In addition, it corrects the hepatic, splenic, hematologic and bone abnormalities observed with types 1 and 3 Gaucher's disease effectively and enhances health-related quality of life.
Related Articles
Novel Diagnostic and Prognostic Modalities in Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/24/09
Relevance Score: 47%
The Antiapoptotic Activity of Melatonin in Neurodegenerative Diseases
CNS Neuroscience & Therapeutics, 11/11/09
Relevance Score: 47%
Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history
Expert Review of Gastroenterology & Hepatology, 10/13/09
Relevance Score: 47%
Fasting Not Necessary for Some Vascular Disease Tests
Ivanhoe, 11/17/09
Relevance Score: 46%
Recognizing and treating cutaneous signs of liver disease
Cleveland Clinic Journal of Medicine, 10/05/09
Relevance Score: 46%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Acetazolamide and midazolam act synergistically to inhibit neuropathic pain
Pain, 12/16/09
Efficacy of azathioprine in mild or moderate relapse in crohn's disease: clinical and endoscopic evaluation
Digestive Endoscopy, 12/16/09
Lessons Learned with Extended-release Epidural Morphine after Total Hip Arthroplasty
Clinical Orthopedics and Related Research, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor